Intraparotid injection of botulinum toxin A as a treatment to control sialorrhea in children with cerebral palsy.

Objective: To determine the efficacy of botulinum toxin A in the management of drooling (sialorrhea) in children and young adults with cerebral palsy.

Design: Twenty-one children were enrolled in an open-label, nonblinded prospective study. Subjective and objective measures were used to determine the effect of botulinum toxin A on drooling and saliva production.